Hiroomi Tada - 15 Sep 2022 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
Chief Medical Officer
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Issuer symbol
TYRA
Transactions as of
15 Sep 2022
Net transactions value
+$4,687
Form type
4
Filing time
19 Sep 2022, 18:20:07 UTC
Previous filing
08 Sep 2022
Next filing
17 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TYRA Common Stock Award $4,687 +612 +0.76% $7.66 81,237 15 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.